Method for the production, recovery and purification of capsular polysaccharide polyribosylribitol phosphate (prp) and use thereof
WO2021046626A2
Anti-inflammatory peptides, pharmaceutical composition containing such peptides, and uses thereof
WO2020102874A1
Compound, use, pharmaceutical composition, method of diagnosis, method of treatment, and method of transportation and/or internalization of a compound into eukaryotic cells
WO2020041851A2
Pharmaceutical composition, process for obtaining and using secondary metabolites produced by the fungus exserohilum rostratum in cell regeneration
BR102019018195A2
PHARMACEUTICAL COMPOSITION, PROCESS OF OBTAINING AND USE OF SECONDARY METABOLITES PRODUCED BY THE FUNGUS EXSEROHILUM ROSTRATUM IN CELLULAR REGENERATION
WO2019126859A1
Fluorescent compound, production method and related use
BR102018074043A2
compound for modulating rlr, tlr, oas and / or oncostatin m pathways, use of it for the preparation of a drug, composition and method for modulating said pathways
BR102018067345A2
production process of recombinant protein, product obtained by the process and its use in the diagnosis of the Zika virus
BR102018067418A2
Pharmaceutical composition, process of obtaining and use of secondary metabolites produced by the fungus exserohilum rostratum in cell and tissue regeneration
BR102018008561A2
process and kit to identify molecular entities involved in osteoarthritis pain
BR102018001339A2
fluorescent compound coupled to a carrier peptide, production process and its use
BR102017028623A2
Pharmaceutical composition for treatment of inflation caused by flaviviridae family virus, and use of the composition
BR102017023688A2
PROCESS FOR THE PREPARATION OF AN ATTENUATED DENGUE TETRAVALENT VACCINE IN INDUSTRIAL SCALE
BR102012024276A2
method and preclinical trial for obtaining a vaccine using bacillus calmette-guérin (bcg) and mycobacterium smegmatis that express the virulence factors bfpa and intimin of enteropathogenic escherichia coli (epec)
